Moolec Science (MLEC) Restructuring Costs (2022 - 2024)
Moolec Science's (MLEC) quarterly Restructuring Costs came in at -$956846.0 in Q4 2024, up 43.23% year-on-year from -$668068.9 in Q1 2024, and up 39.76% quarter-over-quarter from -$1.6 million in Q3 2024.
Moolec Science (MLEC) Restructuring Costs (2022 - 2024) Analysis & Trends
Moolec Science has disclosed Restructuring Costs across 3 years of filings, most recently posting -$956846.0 for Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -956,846.00 |
| Sep 30, 2024 | -1.59 Mn |
| Mar 31, 2024 | -1.61 Mn |
| Dec 31, 2023 | -1.69 Mn |
| Sep 30, 2023 | -1.86 Mn |
| Mar 31, 2023 | 934,941.00 |
| Dec 31, 2022 | -4.47 Mn |
| Sep 30, 2022 | -314,565.00 |
| Mar 31, 2022 | -311,697.00 |